Catalyst Event
Rocket Lab Corp (RKLB) · Other
From Akros U.S. Tech 100 Protective Allocation Monthly Index (A100PAM)
3/18/2026, 12:00:00 AM
On March 18, 2026, Rocket Lab filed for a $1 billion at-the-market equity offering program; analysts estimate the potential dilution will cause a price impact of 10% or more, estimated.
Korean Translation
2026년 3월 18일, 로켓랩은 10억 달러 규모의 시장가 유상증자(ATM) 프로그램을 신청하였으며, 분석가들은 10% 이상의 주가 하락이 있을 것으로 예상됨.
Related Recent Events
CrowdStrike Holdings Inc (CRWD) · Earnings Release
Next earnings release for Q1 2027 is scheduled for 2026-06-09, with analysts forecasting an EPS of $1.07 estimated.
6/9/2026, 12:00:00 AM
Biogen Inc (BIIB) · Other
U.S. FDA decision (PDUFA date) for LEQEMBI IQLIK (lecanemab) subcutaneous autoinjector for treatment initiation in Alzheimer's disease on 2026-05-24; high importance is estimated as FDA approval for a major drug formulation typically results in ≥10% price impact, scheduled.
5/24/2026, 12:00:00 AM
Medtronic PLC (MDT) · Earnings Release
Q4 and Full-Year Fiscal Year 2026 financial results scheduled; expected to have a medium impact as annual results typically influence guidance and investor sentiment.
5/20/2026, 12:00:00 AM
Fair Isaac Corporation (FICO) · Other
FICO World 2026 is scheduled to take place from May 19-22, 2026.
5/19/2026, 12:00:00 AM
Alphabet Inc (GOOGL) · Other
Google I/O 2026 developer conference is scheduled for 2026-05-19. Developer conferences usually have a 1-5% price impact. Updates on AI, Gemini, and Android are expected.
5/19/2026, 12:00:00 AM
GE Aerospace (GE) · Other
The 2026 Annual Shareholders Meeting to be held online on May 5, 2026, scheduled. Routine meetings typically result in minimal price movement.
5/5/2026, 12:00:00 AM